Sandy Srinivas, MD, on Balancing Quality of Life and Survival When Making Decisions About Prostate Cancer Treatment

Posted: Friday, March 19, 2021

Sandy Srinivas, MD, of Stanford Cancer Institute, talks about working with patients who have metastatic castration-resistant prostate cancer to individualize their treatment and help them weigh efficacy, toxicity, and cost.